Strides Pharma Science Limited · NSE: STAR · BSE: 532531
Strides Pharma Science
Quarterly results as filed with BSE. Latest: Q1 FY27 (Apr–Jun 2026), filed 31 Jul 2026.
Q1 FY27 · Consolidated
Revenue
1,265.41₹ Cr
+13.0% vs year ago
Net profit
165.49₹ Cr
+56.7% vs year ago
EPS, basic
17.02₹
+57.4% vs year ago
Net margin
13.1%
+3.6 pts vs year ago
Quarter by quarter
| Quarter | Revenue | YoY | Net profit | YoY | EPS (₹) | Filed |
|---|---|---|---|---|---|---|
| Q1 FY27Apr–Jun 2026 | 1,265.41 | +13.0% | 165.49 | +56.7% | 17.02 | 31 Jul 2026 |
| Q4 FY26Jan–Mar 2026 | 1,323.47 | +11.2% | 129.28 | +51.0% | 13.77 | 18 May 2026 |
| Q3 FY26Oct–Dec 2025 | 1,194.65 | +3.6% | 208.12 | +131.1% | 21.93 | 30 Jan 2026 |
| Q2 FY26Jul–Sep 2025 | 1,220.83 | +1.6% | 131.52 | +40.4% | 13.84 | 31 Oct 2025 |
| Q1 FY26Apr–Jun 2025 | 1,119.74 | +3.0% | 105.59 | +54.6% | 10.81 | 29 Jul 2025 |
| Q4 FY25Jan–Mar 2025 | 1,190.39 | +9.8% | 85.62 | +719.9% | 8.92 | 22 May 2025 |
| Q3 FY25Oct–Dec 2024 | 1,153.67 | +11.2% | 90.04 | +66.6% | 9.56 | 30 Jan 2025 |
| Q2 FY25Jul–Sep 2024 | 1,201.11 | +20.2% | 93.66 | Turned profit | 10.14 | 25 Oct 2024 |
| Q1 FY25Apr–Jun 2024 | 1,087.51 | +16.9% | 68.31 | Turned profit | 7.64 | 30 Jul 2024 |
| Q4 FY24Jan–Mar 2024 | 1,084.04 | +9.9% | 10.44 | Turned profit | 1.98 | 23 May 2024 |
| Q3 FY24Oct–Dec 2023 | 1,037.67 | +20.0% | 54.06 | Turned profit | 5.43 | 31 Jan 2024 |
| Q2 FY24Jul–Sep 2023 | 999.43 | +11.4% | (149.46) | Turned loss | (14.54) | 01 Nov 2023 |
| Q1 FY24Apr–Jun 2023 | 929.99 | −1.1% | (9.36) | Loss narrowed | (0.79) | 02 Aug 2023 |
| Q4 FY23Jan–Mar 2023 | 986.37 | +13.9% | (13.79) | Turned loss | (1.06) | 25 May 2023 |
| Q3 FY23Oct–Dec 2022 | 864.85 | +8.9% | (82.11) | Loss narrowed | (8.86) | 25 Jan 2023 |
| Q2 FY23Jul–Sep 2022 | 897.10 | +24.3% | 18.90 | Turned profit | 2.54 | 15 Nov 2022 |
| Q1 FY23Apr–Jun 2022 | 940.07 | +36.6% | (135.33) | Loss narrowed | (15.13) | 30 Jul 2022 |
| Q4 FY22Jan–Mar 2022 | 866.02 | −4.7% | 28.96 | −33.8% | 3.25 | 25 May 2022 |
| Q3 FY22Oct–Dec 2021 | 794.39 | −4.5% | (126.66) | Turned loss | (13.55) | 10 Feb 2022 |
| Q2 FY22Jul–Sep 2021 | 721.47 | −9.1% | (167.98) | Turned loss | (18.12) | 10 Nov 2021 |
| Q1 FY22Apr–Jun 2021 | 688.37 | −12.0% | (208.57) | Turned loss | (22.88) | 06 Aug 2021 |
| Q4 FY21Jan–Mar 2021 | 908.49 | +46.9% | 43.74 | Turned profit | 5.14 | 27 May 2021 |
| Q3 FY21Oct–Dec 2020 | 832.02 | +13.6% | 35.16 | −61.9% | 4.22 | 04 Feb 2021 |
| Q2 FY21Jul–Sep 2020 | 793.56 | +11.0% | 76.99 | −45.8% | 9.03 | 30 Oct 2020 |
| Q1 FY21Apr–Jun 2020 | 781.80 | +14.0% | 101.84 | 35x | 11.56 | 05 Aug 2020 |
| Q4 FY20Jan–Mar 2020 | 618.64 | −26.3% | (206.57) | Turned loss | (22.77) | 21 May 2020 |
| Q3 FY20Oct–Dec 2019 | 732.44 | −7.8% | 92.33 | −68.9% | 10.48 | 30 Jan 2020 |
| Q2 FY20Jul–Sep 2019 | 715.09 | −2.4% | 141.91 | Turned profit | 15.94 | 26 Oct 2019 |
| Q1 FY20Apr–Jun 2019 | 685.80 | +3.4% | 2.91 | Turned profit | 0.41 | 30 Jul 2019 |
| Q4 FY19Jan–Mar 2019 | 839.70 | — | 44.70 | — | 5.31 | 10 May 2019 |
| Q3 FY19Oct–Dec 2018 | 794.50 | — | 296.43 | — | 32.77 | 29 Jan 2019 |
| Q2 FY19Jul–Sep 2018 | 732.63 | — | (8.70) | — | (1.34) | 31 Oct 2018 |
| Q1 FY19Apr–Jun 2018 | 663.46 | — | (4.16) | — | (0.66) | 08 Aug 2018 |
Standalone results
| Quarter | Revenue | YoY | Net profit | YoY | EPS (₹) | Filed |
|---|---|---|---|---|---|---|
| Q1 FY27Apr–Jun 2026 | 582.65 | +16.9% | 72.93 | +446.4% | 7.91 | 31 Jul 2026 |
| Q4 FY26Jan–Mar 2026 | 605.74 | +9.0% | 16.35 | +1.4% | 1.77 | 18 May 2026 |
| Q3 FY26Oct–Dec 2025 | 553.63 | +0.5% | 121.89 | +716.0% | 13.22 | 30 Jan 2026 |
| Q2 FY26Jul–Sep 2025 | 522.15 | −14.4% | 32.04 | +109.3% | 3.48 | 31 Oct 2025 |
| Q1 FY26Apr–Jun 2025 | 498.62 | −10.1% | 13.35 | +240.6% | 1.45 | 29 Jul 2025 |
| Q4 FY25Jan–Mar 2025 | 555.96 | −10.0% | 16.13 | −69.9% | 1.75 | 22 May 2025 |
| Q3 FY25Oct–Dec 2024 | 550.92 | +5.9% | 14.94 | +487.6% | 1.62 | 30 Jan 2025 |
| Q2 FY25Jul–Sep 2024 | 609.96 | +12.9% | 15.31 | 12x | 1.66 | 25 Oct 2024 |
| Q1 FY25Apr–Jun 2024 | 554.75 | +16.7% | 3.92 | −51.0% | 0.43 | 30 Jul 2024 |
| Q4 FY24Jan–Mar 2024 | 617.63 | +9.6% | 53.66 | −14.0% | 5.84 | 23 May 2024 |
| Q3 FY24Oct–Dec 2023 | 520.01 | +34.5% | 2.54 | −79.7% | 0.28 | 31 Jan 2024 |
| Q2 FY24Jul–Sep 2023 | 540.29 | +12.3% | 1.28 | Turned profit | 0.14 | 01 Nov 2023 |
| Q1 FY24Apr–Jun 2023 | 475.32 | +12.3% | 8.00 | Turned profit | 0.89 | 02 Aug 2023 |
| Q4 FY23Jan–Mar 2023 | 563.56 | +23.7% | 62.40 | −68.9% | 6.91 | 25 May 2023 |
| Q3 FY23Oct–Dec 2022 | 386.51 | −12.1% | 12.54 | Turned profit | 1.39 | 25 Jan 2023 |
| Q2 FY23Jul–Sep 2022 | 481.24 | −16.3% | (4.00) | Turned loss | (0.44) | 15 Nov 2022 |
| Q1 FY23Apr–Jun 2022 | 423.19 | −16.8% | (66.25) | Loss widened | (7.38) | 30 Jul 2022 |
| Q4 FY22Jan–Mar 2022 | 455.66 | −28.1% | 200.50 | +317.1% | 22.33 | 25 May 2022 |
| Q3 FY22Oct–Dec 2021 | 439.56 | +4.4% | (17.60) | Turned loss | (1.96) | 10 Feb 2022 |
| Q2 FY22Jul–Sep 2021 | 575.00 | +49.6% | 18.52 | +35.4% | 2.06 | 10 Nov 2021 |
| Q1 FY22Apr–Jun 2021 | 508.79 | +24.3% | (21.23) | Turned loss | (2.37) | 06 Aug 2021 |
| Q4 FY21Jan–Mar 2021 | 633.60 | +43.4% | 48.08 | +82.3% | 5.36 | 27 May 2021 |
| Q3 FY21Oct–Dec 2020 | 421.08 | +15.5% | 20.49 | +50.1% | 2.29 | 04 Feb 2021 |
| Q2 FY21Jul–Sep 2020 | 384.33 | −9.7% | 13.68 | −70.9% | 1.53 | 30 Oct 2020 |
| Q1 FY21Apr–Jun 2020 | 409.34 | −7.5% | 4.16 | −83.1% | 0.46 | 05 Aug 2020 |
| Q4 FY20Jan–Mar 2020 | 441.74 | +1.7% | 26.37 | −73.3% | 2.94 | 21 May 2020 |
| Q3 FY20Oct–Dec 2019 | 364.47 | −12.1% | 13.65 | −10.8% | 1.52 | 30 Jan 2020 |
| Q2 FY20Jul–Sep 2019 | 425.41 | +25.7% | 47.00 | Turned profit | 5.25 | 26 Oct 2019 |
| Q1 FY20Apr–Jun 2019 | 442.53 | +26.5% | 24.68 | +134.2% | 2.76 | 30 Jul 2019 |
| Q4 FY19Jan–Mar 2019 | 434.56 | — | 98.82 | — | 11.04 | 10 May 2019 |
| Q3 FY19Oct–Dec 2018 | 414.68 | — | 15.31 | — | 1.71 | 29 Jan 2019 |
| Q2 FY19Jul–Sep 2018 | 338.43 | — | (14.30) | — | (1.60) | 31 Oct 2018 |
| Q1 FY19Apr–Jun 2018 | 349.77 | — | 10.54 | — | 1.18 | 08 Aug 2018 |
66 filings on record for this company.